8UQH
 
 | X-ray crystal structure of PRMT4 bound to compound YD-1130 | 分子名称: | 5'-S-(2-{[(3-bromophenyl)methyl]amino}ethyl)-5'-thioadenosine, Histone-arginine methyltransferase CARM1 | 著者 | Bush, M, Noinaj, N, Deng, Y, Huang, R. | 登録日 | 2023-10-23 | 公開日 | 2025-04-02 | 実験手法 | X-RAY DIFFRACTION (1.87 Å) | 主引用文献 | An Adenosine Analogue Library Reveals Insights into Active Sites of Protein Arginine Methyltransferases and Enables the Discovery of a Selective PRMT4 Inhibitor. J.Med.Chem., 67, 2024
|
|
8HTX
 
 | |
8I7X
 
 | Crystal structure of human ClpP in complex with ZG36 | 分子名称: | (6S,9aS)-N-[(4-bromophenyl)methyl]-6-[(2S)-butan-2-yl]-8-[(4-methoxynaphthalen-1-yl)methyl]-4,7-bis(oxidanylidene)-3,6,9,9a-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxamide, ATP-dependent Clp protease proteolytic subunit, mitochondrial | 著者 | Wang, P.Y, Gan, J.H, Yang, C.-G. | 登録日 | 2023-02-02 | 公開日 | 2023-07-19 | 最終更新日 | 2024-05-29 | 実験手法 | X-RAY DIFFRACTION (1.99 Å) | 主引用文献 | Assessment of the structure-activity relationship and antileukemic activity of diacylpyramide compounds as human ClpP agonists. Eur.J.Med.Chem., 258, 2023
|
|
9KNI
 
 | Structural complex of FTO bound with 12j | 分子名称: | 2-OXOGLUTARIC ACID, 3-[[2,6-bis(chloranyl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]thiophene-2-carboxylic acid, Alpha-ketoglutarate-dependent dioxygenase FTO | 著者 | Yang, C.G, Gan, J.H. | 登録日 | 2024-11-19 | 公開日 | 2025-03-12 | 実験手法 | X-RAY DIFFRACTION (2.63 Å) | 主引用文献 | Development of 3-arylaminothiophenic-2-carboxylic acid derivatives as new FTO inhibitors showing potent antileukemia activities. Eur.J.Med.Chem., 289, 2025
|
|
8K9D
 
 | |
5HHV
 
 | |
5HHX
 
 | |
9IRV
 
 | MultiBody Refinement of dimeric DARPin and its bound GFP on a symmetric scaffold | 分子名称: | DARPin, Green fluorescent protein | 著者 | Lu, X, Yan, M, Zhang, H.M, Hao, Q. | 登録日 | 2024-07-16 | 公開日 | 2025-06-04 | 実験手法 | ELECTRON MICROSCOPY (3.47 Å) | 主引用文献 | A large, general and modular DARPin-apoferritin scaffold enables the visualization of small proteins by cryo-EM. Iucrj, 12, 2025
|
|
9IVP
 
 | 24-mer DARPin-apoferritin scaffold in complex with the maltose binding protein | 分子名称: | DARPin,Ferritin heavy chain, N-terminally processed, Maltodextrin-binding protein | 著者 | Lu, X, Yan, M, Zhang, H.M, Hao, Q. | 登録日 | 2024-07-24 | 公開日 | 2025-06-04 | 実験手法 | ELECTRON MICROSCOPY (3 Å) | 主引用文献 | A large, general and modular DARPin-apoferritin scaffold enables the visualization of small proteins by cryo-EM. Iucrj, 12, 2025
|
|
9JMA
 
 | Crystal structure of glycosyltransferase AvpGT | 分子名称: | GalNAc(5)-diNAcBac-PP-undecaprenol beta-1,3-glucosyltransferase, MAGNESIUM ION, URIDINE-5'-DIPHOSPHATE | 著者 | Li, J.H, Wang, Z.Q, Zhang, Z.Y, Chen, W.Q. | 登録日 | 2024-09-20 | 公開日 | 2025-01-29 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Efficient Synthesis of Glycodiversified Nucleoside Analogues by a Thermophilic Promiscuous Glycosyltransferase Acs Catalysis, 15, 2025
|
|
9JN3
 
 | Crystal structure of AvpGT in complex with Ara-A | 分子名称: | 2-(6-AMINO-PURIN-9-YL)-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-3,4-DIOL, GalNAc(5)-diNAcBac-PP-undecaprenol beta-1,3-glucosyltransferase, MAGNESIUM ION, ... | 著者 | Li, J.H, Wang, Z.Q, Zhang, Z.Y, Chen, W.Q. | 登録日 | 2024-09-22 | 公開日 | 2025-01-29 | 実験手法 | X-RAY DIFFRACTION (2.4 Å) | 主引用文献 | Efficient Synthesis of Glycodiversified Nucleoside Analogues by a Thermophilic Promiscuous Glycosyltransferase Acs Catalysis, 15, 2025
|
|
7YC9
 
 | Co-crystal structure of BTK kinase domain with inhibitor | 分子名称: | (7~{S})-2-(4-bromanyl-3,5-dimethoxy-phenyl)-7-(1-propanoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide, 1,2-ETHANEDIOL, Tyrosine-protein kinase BTK | 著者 | Zhou, X. | 登録日 | 2022-07-01 | 公開日 | 2023-05-17 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (1.4 Å) | 主引用文献 | Discovery of BGB-8035, a Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase for B-Cell Malignancies and Autoimmune Diseases. J.Med.Chem., 66, 2023
|
|
8JO4
 
 | Cryo-EM structure of a Legionella effector complexed with actin and ATP | 分子名称: | ADENOSINE-5'-TRIPHOSPHATE, Actin, alpha skeletal muscle, ... | 著者 | Zhou, X.T, Wang, X.F, Tan, J.X, Zhu, Y.Q. | 登録日 | 2023-06-07 | 公開日 | 2024-05-01 | 最終更新日 | 2024-07-24 | 実験手法 | ELECTRON MICROSCOPY (3.04 Å) | 主引用文献 | Legionella effector LnaB is a phosphoryl AMPylase that impairs phosphosignalling. Nature, 631, 2024
|
|
8JO3
 
 | Cryo-EM structure of a Legionella effector complexed with actin and AMP | 分子名称: | ADENOSINE MONOPHOSPHATE, ADENOSINE-5'-TRIPHOSPHATE, Actin, ... | 著者 | Zhou, X.T, Wang, X.F, Tan, J.X, Zhu, Y.Q. | 登録日 | 2023-06-07 | 公開日 | 2024-05-01 | 最終更新日 | 2024-07-24 | 実験手法 | ELECTRON MICROSCOPY (2.66 Å) | 主引用文献 | Legionella effector LnaB is a phosphoryl AMPylase that impairs phosphosignalling. Nature, 631, 2024
|
|
7Y4T
 
 | Crystal structure of cMET kinase domain bound by compound 9I | 分子名称: | 2-[2-[3-(1-methylpyrazol-4-yl)quinolin-6-yl]ethyl]-6-(3-nitrophenyl)pyridazin-3-one, Hepatocyte growth factor receptor | 著者 | Qu, L.Z, Chen, Y.H. | 登録日 | 2022-06-16 | 公開日 | 2022-11-23 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (2.16 Å) | 主引用文献 | Discovery of D6808, a Highly Selective and Potent Macrocyclic c-Met Inhibitor for Gastric Cancer Harboring MET Gene Alteration Treatment. J.Med.Chem., 65, 2022
|
|
7Y4U
 
 | Crystal structure of cMET kinase domain bound by compound 9Y | 分子名称: | Hepatocyte growth factor receptor, ~{N}-methyl-4-[1-[2-[3-(1-methylpyrazol-4-yl)quinolin-6-yl]ethyl]-6-oxidanylidene-pyridazin-3-yl]-2-(trifluoromethyl)benzamide | 著者 | Qu, L.Z, Chen, Y.H. | 登録日 | 2022-06-16 | 公開日 | 2022-11-23 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (2.26 Å) | 主引用文献 | Discovery of D6808, a Highly Selective and Potent Macrocyclic c-Met Inhibitor for Gastric Cancer Harboring MET Gene Alteration Treatment. J.Med.Chem., 65, 2022
|
|
8KH8
 
 | Crystal structure of FGFR4(V550L) kinase domain with 8z | 分子名称: | 1,2-ETHANEDIOL, 1-[4-[(1~{R})-1-[3,5-bis(chloranyl)pyridin-4-yl]ethoxy]-5-cyano-pyridin-2-yl]-3-[6-methanoyl-5-[(4-methyl-2-oxidanylidene-piperazin-1-yl)methyl]-3-(2-morpholin-4-ylethoxy)pyridin-2-yl]urea, Fibroblast growth factor receptor 4, ... | 著者 | Lin, Q.M, Chen, X.J, Chen, Y.H. | 登録日 | 2023-08-21 | 公開日 | 2024-07-31 | 最終更新日 | 2024-11-20 | 実験手法 | X-RAY DIFFRACTION (1.49 Å) | 主引用文献 | Discovery of 6-Formylpyridyl Urea Derivatives as Potent Reversible-Covalent Fibroblast Growth Factor Receptor 4 Inhibitors with Improved Anti-Hepatocellular Carcinoma Activity. J.Med.Chem., 67, 2024
|
|
8KH6
 
 | Crystal structure of FGFR4 kinase domain with 8r | 分子名称: | 1,2-ETHANEDIOL, 1-[4-[(1~{R})-1-[3,5-bis(chloranyl)pyridin-4-yl]ethoxy]-5-cyano-pyridin-2-yl]-3-[5-bromanyl-6-(hydroxymethyl)-3-methoxy-pyridin-2-yl]urea, Fibroblast growth factor receptor 4, ... | 著者 | Lin, Q.M, Chen, X.J, Chen, Y.H. | 登録日 | 2023-08-21 | 公開日 | 2024-07-31 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (1.62 Å) | 主引用文献 | Discovery of 6-Formylpyridyl Urea Derivatives as Potent Reversible-Covalent Fibroblast Growth Factor Receptor 4 Inhibitors with Improved Anti-Hepatocellular Carcinoma Activity. J.Med.Chem., 67, 2024
|
|
8KH9
 
 | Crystal structure of FGFR4(V550M) kinase domain with 8z | 分子名称: | 1,2-ETHANEDIOL, 1-[4-[(1~{R})-1-[3,5-bis(chloranyl)pyridin-4-yl]ethoxy]-5-cyano-pyridin-2-yl]-3-[6-methanoyl-5-[(4-methyl-2-oxidanylidene-piperazin-1-yl)methyl]-3-(2-morpholin-4-ylethoxy)pyridin-2-yl]urea, Fibroblast growth factor receptor 4, ... | 著者 | Lin, Q.M, Chen, X.J, Chen, Y.H. | 登録日 | 2023-08-21 | 公開日 | 2024-07-31 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (1.42 Å) | 主引用文献 | Discovery of 6-Formylpyridyl Urea Derivatives as Potent Reversible-Covalent Fibroblast Growth Factor Receptor 4 Inhibitors with Improved Anti-Hepatocellular Carcinoma Activity. J.Med.Chem., 67, 2024
|
|
8KH7
 
 | Crystal structure of FGFR4 kinase domain with 8zc | 分子名称: | 1,2-ETHANEDIOL, 1-[4-[(1~{R})-1-[3,5-bis(chloranyl)pyridin-4-yl]ethoxy]-5-cyano-pyridin-2-yl]-3-[6-methanoyl-5-[(4-methyl-2-oxidanylidene-piperazin-1-yl)methyl]-3-(2-morpholin-4-ylethoxy)pyridin-2-yl]urea, Fibroblast growth factor receptor 4, ... | 著者 | Lin, Q.M, Chen, X.J, Chen, Y.H. | 登録日 | 2023-08-21 | 公開日 | 2024-07-31 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (1.52 Å) | 主引用文献 | Discovery of 6-Formylpyridyl Urea Derivatives as Potent Reversible-Covalent Fibroblast Growth Factor Receptor 4 Inhibitors with Improved Anti-Hepatocellular Carcinoma Activity. J.Med.Chem., 67, 2024
|
|
7YBO
 
 | Crystal structure of FGFR4 kinase domain with 10z | 分子名称: | Fibroblast growth factor receptor 4, SULFATE ION, ~{N}-[4-[(1~{R})-1-[3,5-bis(chloranyl)pyridin-4-yl]ethoxy]-5-cyano-pyridin-2-yl]-6-bromanyl-5-(hydroxymethyl)-1-(2-morpholin-4-ylethyl)pyrrolo[3,2-b]pyridine-3-carboxamide | 著者 | Chen, X.J, Lin, Q.M, Chen, Y.H. | 登録日 | 2022-06-29 | 公開日 | 2022-11-16 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.307 Å) | 主引用文献 | Design, Synthesis, and Biological Evaluation of 5-Formyl-pyrrolo[3,2- b ]pyridine-3-carboxamides as New Selective, Potent, and Reversible-Covalent FGFR4 Inhibitors. J.Med.Chem., 65, 2022
|
|
7YC3
 
 | Crystal structure of FGFR4 kinase domain with 10t | 分子名称: | 6-bromanyl-~{N}-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-5-methanoyl-1-(2-morpholin-4-ylethyl)pyrrolo[3,2-b]pyridine-3-carboxamide, Fibroblast growth factor receptor 4, GLYCEROL, ... | 著者 | Chen, X.J, Lin, Q.M, Chen, Y.H. | 登録日 | 2022-06-30 | 公開日 | 2022-11-16 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (1.987 Å) | 主引用文献 | Design, Synthesis, and Biological Evaluation of 5-Formyl-pyrrolo[3,2- b ]pyridine-3-carboxamides as New Selective, Potent, and Reversible-Covalent FGFR4 Inhibitors. J.Med.Chem., 65, 2022
|
|
7YC1
 
 | Crystal structure of FGFR4 kinase domain with 10d | 分子名称: | Fibroblast growth factor receptor 4, GLYCEROL, SULFATE ION, ... | 著者 | Chen, X.J, Lin, Q.M, Chen, Y.H. | 登録日 | 2022-06-30 | 公開日 | 2022-11-16 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.535 Å) | 主引用文献 | Design, Synthesis, and Biological Evaluation of 5-Formyl-pyrrolo[3,2- b ]pyridine-3-carboxamides as New Selective, Potent, and Reversible-Covalent FGFR4 Inhibitors. J.Med.Chem., 65, 2022
|
|
7YBP
 
 | Crystal structure of FGFR4(V550L) kinase domain with 10z | 分子名称: | Fibroblast growth factor receptor 4, SULFATE ION, ~{N}-[4-[(1~{R})-1-[3,5-bis(chloranyl)pyridin-4-yl]ethoxy]-5-cyano-pyridin-2-yl]-6-bromanyl-5-(hydroxymethyl)-1-(2-morpholin-4-ylethyl)pyrrolo[3,2-b]pyridine-3-carboxamide | 著者 | Chen, X.J, Lin, Q.M, Chen, Y.H. | 登録日 | 2022-06-29 | 公開日 | 2022-11-16 | 最終更新日 | 2024-11-20 | 実験手法 | X-RAY DIFFRACTION (2.243 Å) | 主引用文献 | Design, Synthesis, and Biological Evaluation of 5-Formyl-pyrrolo[3,2- b ]pyridine-3-carboxamides as New Selective, Potent, and Reversible-Covalent FGFR4 Inhibitors. J.Med.Chem., 65, 2022
|
|
7YBX
 
 | Crystal structure of FGFR4(V550M) kinase domain with 10z | 分子名称: | Fibroblast growth factor receptor 4, SULFATE ION, ~{N}-[4-[(1~{R})-1-[3,5-bis(chloranyl)pyridin-4-yl]ethoxy]-5-cyano-pyridin-2-yl]-6-bromanyl-5-(hydroxymethyl)-1-(2-morpholin-4-ylethyl)pyrrolo[3,2-b]pyridine-3-carboxamide | 著者 | Chen, X.J, Lin, Q.M, Chen, Y.H. | 登録日 | 2022-06-30 | 公開日 | 2022-11-16 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (2.233 Å) | 主引用文献 | Design, Synthesis, and Biological Evaluation of 5-Formyl-pyrrolo[3,2- b ]pyridine-3-carboxamides as New Selective, Potent, and Reversible-Covalent FGFR4 Inhibitors. J.Med.Chem., 65, 2022
|
|